发明名称 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with anglogenesis inhibitor.
摘要 Disclosed are compositions and methods for enhancing a cytocidal immune response directed against a preselected cell-type in a mammal. The methods and compositions rely on a combination of an antibody-cytokine immunoconjugate and an angiogenesis inhibitor. Once administered to the mammal, the immunoconjugate induces an immune response against the preselected cell-type, for example, a cancer cell which, as a result of the synergy with the angiogenesis inhibitor, is greater than the immune response induced by the immunoconjugate alone. The methods and compositions are particularly useful at killing solid tumors or virally-infected cells in a mammal.
申请公布号 ZA200005475(B) 申请公布日期 2001.11.13
申请号 ZA20000005475 申请日期 2000.10.06
申请人 LEXIGEN PHARMACEUTICALS CORPORATION 发明人 STEPHEN D. GILLIES
分类号 A61K45/00;A61K31/336;A61K31/435;A61K38/00;A61K38/19;A61K38/39;A61K39/395;A61K47/48;A61P31/12;A61P35/00;C07K19/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址